Self-amplification system for recombinant adeno-associated virus production

Area of Science:

• Biotechnology
• Molecular Biology
• Virology

Background:

• Current recombinant adeno-associated virus (rAAV) production systems often require extensive plasmid transfection and helper virus infection.
• Simplifying these production methods is crucial for efficient and scalable rAAV generation.

Purpose of the Study:

• To simplify recombinant adeno-associated virus (rAAV) production by utilizing rAAV itself as a DNA source.
• To determine the optimal infection timing and input dose for rAAV self-amplification.

Main Methods:

• Transfection of 293 cells with AAV-helper and adenovirus-helper plasmids.
• Infection of transfected cells with varying doses of rAAV (input DNA source) at different time points.
• Assessment of rAAV production yield based on input rAAV purity and dose.

Main Results:

• Infection with 100 particles/cell of rAAV immediately post-transfection resulted in 9- to 20-fold self-amplification.
• rAAV yields were comparable to traditional adenovirus-free transfection methods, regardless of input rAAV purity (CsCl-purified or crude).
• The strategy demonstrated significant rAAV self-amplification, reducing the reliance on large plasmid quantities.

Conclusions:

• Infecting cells with rAAV can serve as an effective DNA source, simplifying large-scale transfection protocols.
• This self-amplification strategy is a valuable advancement for efficient rAAV production, particularly for packaging cell lines.
• The findings pave the way for more streamlined and cost-effective rAAV manufacturing processes.